272
Views
0
CrossRef citations to date
0
Altmetric
Brief Reports

Effects of methylphenidate on subjective sleep parameters in adults with ADHD: a prospective, non-randomized, non-blinded 6-week trial

, ORCID Icon, , , , & show all
Pages 102-107 | Received 08 Nov 2021, Accepted 08 Apr 2022, Published online: 28 May 2022

References

  • Brevik EJ, Lundervold AJ, Halmøy A, et al. Prevalence and clinical correlates of insomnia in adults with attention-deficit hyperactivity disorder. Acta Psychiatr Scand. 2017;136(2):220–227.
  • Díaz-Román A, Mitchell R, Cortese S. Sleep in adults with ADHD: Systematic review and Meta-analysis of subjective and objective studies. Neurosci Biobehav Rev. 2018;89(March):61–71.
  • Lecendreux M, Cortese S. Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future. Expert Rev Neurother. 2007;7(12):1799–1806.
  • Gregory AM, Agnew-Blais J, Matthews T, et al. Associations between ADHD and sleep quality: Longitudinal analyses from a nationally-representative cohort of twins. J Clin Child Adolesc Psychol. 2017;46(2):284–294.
  • Boonstra AM, Kooij JJS, Oosterlaan J, et al. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep. 2007;30(4):433–442.
  • Sobanski E, Schredl M, Kettler N, et al. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep. 2008;31(3):375–381.
  • Bushe C, Day K, Reed V, et al. A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients. J Psychopharmacol. 2016;30(5):444–458.
  • Sundhedsstyrelsen. 2015. National klinisk retningslinje for udredning og behandling af ADHD hos voksne. Retrieved from https://www.sst.dk/da/nyheder/2015/∼/media/91742BB2537F480E9481E415144C3687.ashx.
  • Cortese S. Pharmacologic treatment of attention Deficit-Hyperactivity Disorder. N Engl J Med. 2020;383(11):1050–1056.
  • Mishara AL, Goldberg TE. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol Psychiatry. 2004;55(10):1013–1022.
  • Faraone SV, Po MD, Komolova M, et al. Sleep-Associated adverse events during methylphenidate treatment of Attention-Deficit/hyperactivity disorder: a meta-analysis stephen. J Clin Psychiatr. 2019;80(3):e1–e18.
  • Solleveld MM, Schrantee A, Baek HK, et al. Effects of 16 weeks of methylphenidate treatment on actigraph-assessed sleep measures in medication-naive children with ADHD. Front Psychiatry. 2020;11(February):82–89.
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545.
  • Goodman DW, Starr HL, Ma YW, et al. Randomized, 6-week, placebo-controlled study of treatment for adult attention-deficit/hyperactivity disorder: Individualized dosing of osmotic-release oral system (OROS) methylphenidate with a goal of symptom remission. J Clin Psychiatr. 2017;78(01):105–114.
  • Weiss MD, Surman C, Khullar A, et al. Effect of a multi-layer, extended-release methylphenidate formulation (PRC-063) on sleep in adults with ADHD: a randomized, double-blind, forced-dose, placebo-controlled trial followed by a 6-month open-label extension. CNS Drugs. 2021;35(6):667–679.
  • Fredriksen M, Golparian N, Beiske K, et al. Impact of methylphenidate on sleep problems in adults with ADHD: a pilot polysomnography study. Nord J Psychiatry. 2021;75(3):234–238.
  • Low A, Vangkilde S, Sommer J, et al. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment. Psychol Med. 2019;49(15):2617–2625.
  • Buysse DJ, Reynolds CF, Monk TH, et al. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatr Res. 1989;28(2):193–213.
  • Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–256.
  • Spencer T, Adler L, Qiao M. Validation of the adult ADHD investigator symptom rating scale (AISRS). Journal of Attention Disorders. 2010;14(1):57–68.
  • Weiss MD, Childress AC, Donnelly GAE. Efficacy and safety of PRC-063, extended-release multilayer methylphenidate in adults with ADHD including 6-month open-label extension. J Atten Disord. 2021;25(10):1417–1428.
  • Becker SP, Froehlich TE, Epstein JN. Effects of methylphenidate on sleep functioning in children with Attention-Deficit/hyperactivity disorder. J Dev Behav Pediatr. 2016;37(5):395–404.
  • Cortese S, Konofal E, Lecendreux M. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role?. Med Hypotheses. 2008;71(5):770–775. doi:10.1016/j.mehy.2008.06.017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.